{"id":"W2795095949","doi":"10.1111/jns.12267","title":"A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol","year":2018,"lang":"en","type":"article","venue":"Journal of the Peripheral Nervous System","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Polyradiculoneuropathy; Tolerability; Chronic inflammatory demyelinating polyneuropathy; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Clinical trial; Corticosteroid; Antibody; Pediatrics; Immunology; Guillain-Barre syndrome","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291503,0.00034521,0.001248174,0.0001528378,0.0001486756,0.0000280227,0.0002961314,0.00006751826,0.00002145329],"category_scores_gemma":[0.0001562103,0.0001866701,0.0001722827,0.0002648955,0.0001598513,0.000112666,0.0001088456,0.0003540401,2.627192e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000262833,"about_ca_system_score_gemma":0.0002405721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001246312,"about_ca_topic_score_gemma":0.0001834058,"domain_scores_codex":[0.9957584,0.001157219,0.001753333,0.000263756,0.000738253,0.000329052],"domain_scores_gemma":[0.9971339,0.00009141848,0.001780798,0.0003754557,0.0004908769,0.0001275916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7876796,0.02583538,0.1458038,0.001213003,0.0007259613,0.0002063693,0.02370126,0.0006841802,0.007370624,0.000001369845,0.00003014728,0.006748294],"study_design_scores_gemma":[0.8086826,0.07064788,0.1019226,0.001499668,0.000411922,0.00009116918,0.01431101,0.001706998,0.0004775953,9.470166e-7,0.00001350871,0.00023405],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9324774,0.00008921597,0.00008360226,0.00001850894,0.0001705724,0.06713767,0.000002443418,0.00001305618,0.000007521533],"genre_scores_gemma":[0.998141,0.000002710792,0.00007675046,0.00001384324,0.0001504424,0.001534152,3.051049e-7,0.00004365814,0.00003715027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06566357,"threshold_uncertainty_score":0.7612188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01173143458194222,"score_gpt":0.2613315869980229,"score_spread":0.2496001524160807,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}